UTHR
United Therapeutics CorporationNASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$24.13B
P/E Ratio
21.01
EPS
$27.06
Beta
0.59
52W High
$609.35
52W Low
$272.12
50-Day MA
$564.33
200-Day MA
$476.03
Dividend Yield
—
Profit Margin
40.60%
Forward P/E
20.66
PEG Ratio
2.32
About United Therapeutics Corporation
United Therapeutics Corporation, a biotechnology company, is dedicated to the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. The company is headquartered in Silver Spring, Maryland.
Fundamentals
| Revenue (TTM) | $3.17B |
| Gross Profit (TTM) | $2.74B |
| EBITDA | $1.55B |
| Operating Margin | 41.70% |
| Return on Equity | 20.30% |
| Return on Assets | 12.60% |
| Revenue/Share (TTM) | $72.12 |
| Book Value | $139.98 |
| Price-to-Book | 4.07 |
| Price-to-Sales (TTM) | 7.61 |
| EV/Revenue | 6.6 |
| EV/EBITDA | 12.20 |
| Quarterly Earnings Growth (YoY) | -12.20% |
| Quarterly Revenue Growth (YoY) | -1.60% |
| Shares Outstanding | $42.45M |
| Float | $38.91M |
| % Insiders | 2.04% |
| % Institutions | 102.07% |
Historical Volatility
HV 10-Day
14.75%
HV 20-Day
26.93%
HV 30-Day
23.87%
HV 60-Day
40.34%
HV Rank
21.4%
Volatility is currently contracting
Analyst Ratings
Consensus ($665.23 target)
2
Strong Buy9
Buy4
HoldMore HEALTHCARE Stocks
Data last updated: 5/25/2026